|
1
|
Sloma I, Jiang X, Eaves AC and Eaves CJ:
Insights into the stem cells of chronic myeloid leukemia. Leukemia.
24:1823–1833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hart GW: Glycosylation. Curr Opin Cell
Biol. 4:1017–1023. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunphy WG, Brands R and Rothman JE:
Attachment of terminal N-acetylglucosamine to asparagine-linked
oligosaccharides occurs in central cisternae of the Golgi stack.
Cell. 40:463–472. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kelly RJ, Rouquier S, Giorgi D, Lennon GG
and Lowe JB: Sequence and expression of a candidate for the human
Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2).
Homozygosity for an enzyme-inactivating nonsense mutation commonly
correlates with the non-secretor phenotype. J Biol Chem.
270:4640–4649. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larsen RD, Ernst LK, Nair RP and Lowe JB:
Molecular cloning, sequence, and expression of a human
GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA
that can form the H blood group antigen. Proc Natl Acad Sci USA.
87:6674–6678. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun J, Thurin J, Cooper HS, Wang P,
Mackiewicz M, Steplewski Z and Blaszczyk-Thurin M: Elevated
expression of H type GDP-L-fucose:beta-D-galactoside
alpha-2-L-fucosyltransferase is associated with human colon
adenocarcinoma progression. Proc Natl Acad Sci USA. 92:5724–5728.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC,
Wu CY and Yu YL: Downregulation of microRNA-15b by hepatitis B
virus X enhances hepatocellular carcinoma proliferation via
fucosyltransferase 2-induced Globo H expression. Int J Cancer.
134:1638–1647. 2014. View Article : Google Scholar
|
|
8
|
Iwamori M, Tanaka K, Kubushiro K, Lin B,
Kiguchi K, Ishiwata I, Tsukazaki K and Nozawa S: Alterations in the
glycolipid composition and cellular properties of ovarian
carcinoma-derived RMG-1 cells on transfection of the
α1,2-fucosyltransferase gene. Cancer Sci. 96:26–30. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hao YY, Lin B, Zhao Y, Zhang YH, Li FF,
Diao B, Ou YL and Zhang SL: alpha1,2-fucosyltransferase gene
transfection influences on biological behavior of ovarian
carcinoma-derived RMG-I cells. Fen Zi Xi Bao Sheng Wu Xue Bao.
41:435–442. 2008.In Chinese.
|
|
10
|
Fischer OM, Hart S and Ullrich A:
Dissecting the epidermal growth factor receptor signal
transactivation pathway. Methods Mol Biol. 327:85–97.
2006.PubMed/NCBI
|
|
11
|
Iida M, Brand TM, Campbell DA, Starr MM,
Luthar N, Traynor AM and Wheeler DL: Targeting AKT with the
allosteric AKT inhibitor MK-2206 in non-small cell lung cancer
cells with acquired resistance to cetuximab. Cancer Biol Ther.
14:481–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan P, Wang J, Santen RJ and Yue W:
Long-term treatment with tamoxifen facilitates translocation of
estrogen receptor alpha out of the nucleus and enhances its
interaction with EGFR in MCF-7 breast cancer cells. Cancer Res.
67:1352–1360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kassouf W, Dinney CP, Brown G, McConkey
DJ, Diehl AJ, Bar-Eli M and Adam L: Uncoupling between epidermal
growth factor receptor and downstream signals defines resistance to
the antiproliferative effect of Gefitinib in bladder cancer cells.
Cancer Res. 65:10524–10535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lattová E, Tomanek B, Bartusik D and
Perreault H: N-glycomic changes in human breast carcinoma MCF-7 and
T-lymphoblastoid cells after treatment with herceptin and
herceptin/Lipoplex. J Proteome Res. 9:1533–1540. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shu H, Zhang S, Kang X, Li S, Qin X, Sun
C, Lu H and Liu Y: Protein expression and fucosylated glycans of
the serum haptoglobin-{beta} subunit in hepatitis B virus-based
liver diseases. Acta Biochim Biophys Sin (Shanghai). 43:528–534.
2011. View Article : Google Scholar
|
|
16
|
Mejías-Luque R, López-Ferrer A, Garrido M,
Fabra A and de Bolós C: Changes in the invasive and metastatic
capacities of HT-29/M3 cells induced by the expression of
fucosyltransferase 1. Cancer Sci. 98:1000–1005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vasseur JA, Goetz JA, Alley WR Jr and
Novotny MV: Smoking and lung cancer-induced changes in
N-glycosylation of blood serum proteins. Glycobiology.
22:1684–1708. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawai S, Kato S, Imai H, Okada Y and
Ishioka C: Suppression of FUT1 attenuates cell proliferation in the
HER2-overexpressing cancer cell line NCI-N87. Oncol Rep. 29:13–20.
2013.
|
|
19
|
Zhang Z, Sun P, Liu J, Fu L, Yan J, Liu Y,
Yu L, Wang X and Yan Q: Suppression of FUT1/FUT4 expression by
siRNA inhibits tumor growth. Biochim Biophys Acta. 1783:287–296.
2008. View Article : Google Scholar
|
|
20
|
Hoffmann K, Xiao Z, Franz C, Mohr E, Serba
S, Büchler MW and Schemmer P: Involvement of the epidermal growth
factor receptor in the modulation of multidrug resistance in human
hepatocellular carcinoma cells in vitro. Cancer Cell Int.
11:402011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Martindale JL and Holbrook NJ:
Requirement for ERK activation in cisplatin-induced apoptosis. J
Biol Chem. 275:39435–39443. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barancík M, Bohácová V, Kvackajová J,
Hudecová S, Krizanová O and Breier A: SB203580, a specific
inhibitor of p38-MAPK pathway, is a new reversal agent of
P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci.
14:29–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang JM, Vassil AD and Hait WN: Activation
of phospholipase C induces the expression of the multidrug
resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol.
60:674–680. 2001.PubMed/NCBI
|
|
24
|
Katayama K, Yoshioka S, Tsukahara S,
Mitsuhashi J and Sugimoto Y: Inhibition of the mitogen-activated
protein kinase pathway results in the down-regulation of
P-glycoprotein. Mol Cancer Ther. 6:2092–2102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garcia R, Franklin RA and McCubrey JA: EGF
induces cell motility and multi-drug resistance gene expression in
breast cancer cells. Cell Cycle. 5:2820–2826. 2006. View Article : Google Scholar : PubMed/NCBI
|
